Naresh Jain

Naresh Jain

Company: NJ Bio, Inc.

Job title: Chief Executive Officer


Accelerated Pathway from Antibody to ADC 10:30 am

The pathway from antibody to ADCs is complex, resource intensive, and time-consuming. There are numerous platform-based solutions including various classes of payloads, differing linker chemistries, and conjugation technologies to evaluate. All of these can seem like a minefield.  We will demonstrate how having high-quality material, expertise and the right technology can accelerate your ADC programs.Read more

day: day 2- am

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.